Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 14

1.

Characterization of echinocandin-resistant mutants of Candida albicans: genetic, biochemical, and virulence studies.

Kurtz MB, Abruzzo G, Flattery A, Bartizal K, Marrinan JA, Li W, Milligan J, Nollstadt K, Douglas CM.

Infect Immun. 1996 Aug;64(8):3244-51.

2.

New semisynthetic pneumocandins with improved efficacies against Pneumocystis carinii in the rat.

Schmatz DM, Powles MA, McFadden D, Nollstadt K, Bouffard FA, Dropinski JF, Liberator P, Andersen J.

Antimicrob Agents Chemother. 1995 Jun;39(6):1320-3.

3.

Increased antifungal activity of L-733,560, a water-soluble, semisynthetic pneumocandin, is due to enhanced inhibition of cell wall synthesis.

Kurtz MB, Douglas C, Marrinan J, Nollstadt K, Onishi J, Dreikorn S, Milligan J, Mandala S, Thompson J, Balkovec JM, et al.

Antimicrob Agents Chemother. 1994 Dec;38(12):2750-7.

4.

Use of beta-1,3-glucan-specific antibody to study the cyst wall of Pneumocystis carinii and effects of pneumocandin B0 analog L-733,560.

Nollstadt KH, Powles MA, Fujioka H, Aikawa M, Schmatz DM.

Antimicrob Agents Chemother. 1994 Oct;38(10):2258-65.

5.

Pneumocandins from Zalerion arboricola. IV. Biological evaluation of natural and semisynthetic pneumocandins for activity against Pneumocystis carinii and Candida species.

Schmatz DM, Abruzzo G, Powles MA, McFadden DC, Balkovec JM, Black RM, Nollstadt K, Bartizal K.

J Antibiot (Tokyo). 1992 Dec;45(12):1886-91.

6.

In vitro antifungal activities and in vivo efficacies of 1,3-beta-D-glucan synthesis inhibitors L-671,329, L-646,991, tetrahydroechinocandin B, and L-687,781, a papulacandin.

Bartizal K, Abruzzo G, Trainor C, Krupa D, Nollstadt K, Schmatz D, Schwartz R, Hammond M, Balkovec J, Vanmiddlesworth F.

Antimicrob Agents Chemother. 1992 Aug;36(8):1648-57.

7.

Preparation and structure-activity relationships of simplified analogues of the antifungal agent cilofungin: a total synthesis approach.

Zambias RA, Hammond ML, Heck JV, Bartizal K, Trainor C, Abruzzo G, Schmatz DM, Nollstadt KM.

J Med Chem. 1992 Jul 24;35(15):2843-55.

PMID:
1495015
8.

Purification and characterization of a protective antigen from Eimeria tenella.

Karkhanis YD, Nollstadt KA, Bhogal BS, Ravino O, Pellegrino R, Crane MS, Murray PK, Turner MJ.

Infect Immun. 1991 Mar;59(3):983-9.

9.

L-687,781, a new member of the papulacandin family of beta-1,3-D-glucan synthesis inhibitors. I. Fermentation, isolation, and biological activity.

VanMiddlesworth F, Omstead MN, Schmatz D, Bartizal K, Fromtling R, Bills G, Nollstadt K, Honeycutt S, Zweerink M, Garrity G, et al.

J Antibiot (Tokyo). 1991 Jan;44(1):45-51.

10.

Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.

Schmatz DM, Romancheck MA, Pittarelli LA, Schwartz RE, Fromtling RA, Nollstadt KH, Vanmiddlesworth FL, Wilson KE, Turner MJ.

Proc Natl Acad Sci U S A. 1990 Aug;87(15):5950-4.

11.

Potential of the sulfobetaine detergent Zwittergent 3-12 as a desorbing agent in biospecific and bioselective affinity chromatography.

Nollstadt KH, Karkhanis YD, Gnozzio MJ, Crane MS, Gurnett AM, Schmatz DM, Turner MJ.

J Chromatogr. 1989 Dec 29;497:87-100.

PMID:
2625482
12.
13.

Induction of antibody and cellular immune responses in chickens against Eimeria tenella by anti-idiotype.

Bhogal BS, Nollstadt K, Kirk K, Karkhanis YD, Jacobson EB.

Prog Clin Biol Res. 1987;238:307-20. No abstract available.

PMID:
3496615
14.

Isolation of a pure dextranase from Penicillium funiculosum.

Chaiet L, Kempf AJ, Harman R, Kaczka E, Weston R, Nollstadt K, Wolf FJ.

Appl Microbiol. 1970 Sep;20(3):421-6.

Supplemental Content

Loading ...
Support Center